Literature DB >> 25385231

When Cri du chat syndrome meets Edwards syndrome.

Yingjun Xie1, Yi Zhou1, Jianzhu Wu1, Yunxia Sun2, Yongzhen Chen1, Baojiang Chen1.   

Abstract

It has been well established that the 5p deletion causes Cri du chat syndrome, typically characterized by a cat‑like cry, and that duplication of 18q causes Edwards syndrome; the two are rare genetic abnormalities that separately lead to physical and mental impairments. However, the severity of the clinicopathological characteristics that arise when these two aberrations occur in one patient is unknown. Here, the first case in our knowledge of a single patient (a two‑year‑old female) with 5p partial monosomy and 18q partial trisomy is described. In the present study, chromosome microarray analysis was performed, which identified the imbalance of chromosomes 5 and 18 in the patient. The chromosome aberrations were further confirmed by fluorescence in situ hybridization. By comparing the phenotypes of combined case with those of the individual syndromes, severe clinical phenotypes of the 5p (5p15.33‑p13.3) deletion were confirmed, however, the net effect of the duplication of 18q22.3‑q23 was not determined, as this duplication only appeared to have a weak effect on the patient's phenotypes. The correlation between these chromosomal aberrations and their clinical features has implications for the identification of critical regions of 5p and 18q, particularly for the functional mapping of chromosome 18.

Entities:  

Mesh:

Year:  2014        PMID: 25385231     DOI: 10.3892/mmr.2014.2920

Source DB:  PubMed          Journal:  Mol Med Rep        ISSN: 1791-2997            Impact factor:   2.952


  1 in total

1.  Report of a patient with a de novo non-recurrent duplication of 17p11.2p12 and Yq11 deletion.

Authors:  Liliana Fernández-Hernández; María José Navarro-Cobos; Miguel Angel Alcántara-Ortigoza; Sandra Elena Ramos-Ángeles; Bertha Molina-Álvarez; Sinhué Díaz-Cuéllar; Bárbara Asch-Daich; Ariadna González-Del Angel
Journal:  Mol Cytogenet       Date:  2019-08-01       Impact factor: 2.009

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.